Nimotuzumab Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH4008
Add to Compare
$306.00

Bulk Nimotuzumab Biosimilar - Research Grade

Product Specific Citations:

Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates

Tikum et al. Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates. Pharmaceutics (2022). 

 

Bulk Nimotuzumab Biosimilar - Research Grade

Product Specific Citations:

Tikum et al. Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates. Pharmaceutics (2022). 

Product Benefits:

ichorbio's Nimotuzumab Biosimilar - Research Grade is manufactured in a cGMP compliant facility.

Size:

ichorbio's research grade nimotuzumab biosimilar is available in the following sizes: 5mg, 10mg, 20mg, 50mg, 100mg ichorbio regularly manufactures bulk multi-gram amounts of our nimotuzumab biosimilar - please contact us for pricing.

Target:

EGFR

Clone:

n/a

Isotype:

IgG1

Other Names:

Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, ERBB, ERBB1, HER1

Host:

Humanized

Species Reactivity:

Human

Specificity:

Detects human EGFR.

Purification Method:

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background:

Nimotuzumab biosimilar has a humanized human-mouse h-R3 heavy chain and a humanized human-mouse h-R3κ-chain. nimotuzumab binds to the epidermal growth factor receptor (EGFR), a signalling protein that normally controls cell division.

Concentration:

1.0 - 5.0 mg/ml

Formulation:

Sterile, clear, colorless solution without preservatives, containing sodium dihydrogen phosphate, phosphoric acid disodium hydrogen, sodium chloride and polysorbate 80. BSA and Azide free.

Purity:

>95% by SDS-PAGE and HPLC

Endotoxin:

≤ 0.75 EU/mg as determined by the LAL method

Storage:

This antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.

Applications:

Functional Assays

Application Notes:

Each investigator should determine their own optimal working dilution for specific applications.

Use: ichorbio's nimotuzumab biosimilar is for research use only (RUO). Isotype Control:

Bulk Human IgG1 Isotype Control (IB1) [ICH2254]

More Information
Concentration 14.83mg/ml
Isotype IgG1
Host Humanized
citation

Bulk Nimotuzumab Biosimilar - Research Grade

Product Specific Citations:

Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates

Tikum et al. Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates. Pharmaceutics (2022). 

 

Use Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Storage Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at ï؟½80°C. Avoid Repeated Freeze Thaw Cycles.
Endotoxin ≤ 1.0 EU/mg as determined by the LAL method
Purity >95% by SDS-PAGE and HPLC
Formulation Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
Purification Method This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Specificity Detects human EGFR. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Nimotuzumab.
Species Reactivity Human
Target EGFR
Shipping Conditions Blue ice
background Nimotuzumab biosimilar has a humanized human-mouse h-R3 heavy chain and a humanized human-mouse h-R3_-chain. nimotuzumab binds to the epidermal growth factor receptor (EGFR), a signalling protein that normally controls cell division.
Other names Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, ERBB, ERBB1, HER1
UniProt P00533
Buffer ICH3001-100ml ICH3002-100ml ICH3003-100ml
Sequence https://www.imgt.org/mAb-DB/
Write Your Own Review
You're reviewing:Nimotuzumab Biosimilar - Research Grade
Your Rating
Back to Top